BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18680555)

  • 1. Mitochondrial alterations in Parkinson's disease: new clues.
    Vila M; Ramonet D; Perier C
    J Neurochem; 2008 Oct; 107(2):317-28. PubMed ID: 18680555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunctions in Parkinson's disease.
    Gautier CA; Corti O; Brice A
    Rev Neurol (Paris); 2014 May; 170(5):339-43. PubMed ID: 24119854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.
    Esteves AR; Gozes I; Cardoso SM
    Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a pathogenic role for mitochondria in Parkinson's disease?
    Vives-Bauza C; de Vries RL; Tocilescu MA; Przedborski S
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S241-4. PubMed ID: 20083000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways of neurodegeneration in Parkinson's disease.
    Dawson TM; Dawson VL
    Science; 2003 Oct; 302(5646):819-22. PubMed ID: 14593166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease.
    Burbulla LF; Krüger R
    J Neurol Sci; 2011 Jul; 306(1-2):1-8. PubMed ID: 21513949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: a speculative synthesis.
    Lamberts JT; Hildebrandt EN; Brundin P
    Neurobiol Dis; 2015 May; 77():276-83. PubMed ID: 25046996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in Parkinson's disease.
    Winklhofer KF; Haass C
    Biochim Biophys Acta; 2010 Jan; 1802(1):29-44. PubMed ID: 19733240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological mechanisms of Parkinson's disease].
    Matsui H; Takahashi R
    Brain Nerve; 2009 Apr; 61(4):441-6. PubMed ID: 19378814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria in the aetiology and pathogenesis of Parkinson's disease.
    Schapira AH
    Lancet Neurol; 2008 Jan; 7(1):97-109. PubMed ID: 18093566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease.
    Wang HQ; Takahashi R
    Antioxid Redox Signal; 2007 May; 9(5):553-61. PubMed ID: 17465880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein and mitochondrial dysfunction in Parkinson's disease.
    Mullin S; Schapira A
    Mol Neurobiol; 2013 Apr; 47(2):587-97. PubMed ID: 23361255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?
    Franco-Iborra S; Vila M; Perier C
    Neuroscientist; 2016 Jun; 22(3):266-77. PubMed ID: 25761946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
    Lin TK; Liou CW; Chen SD; Chuang YC; Tiao MM; Wang PW; Chen JB; Chuang JH
    Chang Gung Med J; 2009; 32(6):589-99. PubMed ID: 20035637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage.
    Stichel CC; Zhu XR; Bader V; Linnartz B; Schmidt S; Lübbert H
    Hum Mol Genet; 2007 Oct; 16(20):2377-93. PubMed ID: 17412759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.